These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
79 related items for PubMed ID: 3468486
1. Radioimmunotherapy of xenografts of human pancreatic carcinomas--intravenous and intratumoral application of 131I-labelled monoclonal antibodies. Klapdor R, Lander S, Bahlo M, Montz R. Nuklearmedizin; 1986 Dec; 25(6):235-8. PubMed ID: 3468486 [Abstract] [Full Text] [Related]
2. Comparison of multiple bolus and continuous injections of 131I-labeled CC49 for therapy in a colon cancer xenograft model. Buchsbaum DJ, Khazaeli MB, Mayo MS, Roberson PL. Clin Cancer Res; 1999 Oct; 5(10 Suppl):3153s-3159s. PubMed ID: 10541357 [Abstract] [Full Text] [Related]
3. [Immunoscintigraphy and radioimmunotherapy of transplanted pancreatic carcinoma. Experimental animal studies with 131I-labeled monoclonal antibodies against CA 19-9, CEA and CA 125]. Klapdor R, Montz R, Greten H, Chatal JF, Douillard JY, Saccavini JC, Dietel M. Nuklearmedizin; 1985 Dec; 24(5-6):227-31. PubMed ID: 3867855 [Abstract] [Full Text] [Related]
4. Fractionated radioimmunotherapy of human colon carcinoma xenografts with 131I-labeled monoclonal antibody CC49. Buchsbaum D, Khazaeli MB, Liu T, Bright S, Richardson K, Jones M, Meredith R. Cancer Res; 1995 Dec 01; 55(23 Suppl):5881s-5887s. PubMed ID: 7493364 [Abstract] [Full Text] [Related]
5. Improved radioimmunotherapeutic efficacy of an anticarcinoma monoclonal antibody (131I-CC49) when given in combination with gamma-interferon. Greiner JW, Ullmann CD, Nieroda C, Qi CF, Eggensperger D, Shimada S, Steinberg SM, Schlom J. Cancer Res; 1993 Feb 01; 53(3):600-8. PubMed ID: 8425194 [Abstract] [Full Text] [Related]
6. Systemic radiotherapy with monoclonal antibodies. An experimental study with human neuroblastoma xenografts in nude mice. Sautter-Bihl ML, Matzku S, Bihl H. Strahlenther Onkol; 1993 Jul 01; 169(7):431-7. PubMed ID: 8342117 [Abstract] [Full Text] [Related]
7. Effect of multiple, repeated doses of radioimmunotherapy on target antigen expression (breast MUC-1 mucin) in breast carcinomas. Peterson JA, Blank EW, Ceriani RL. Cancer Res; 1997 Mar 15; 57(6):1103-8. PubMed ID: 9067279 [Abstract] [Full Text] [Related]
8. Enhanced antitumor activity of combination radioimmunotherapy (131I-labeled monoclonal antibody A33) with chemotherapy (fluorouracil). Tschmelitsch J, Barendswaard E, Williams C, Yao TJ, Cohen AM, Old LJ, Welt S. Cancer Res; 1997 Jun 01; 57(11):2181-6. PubMed ID: 9187118 [Abstract] [Full Text] [Related]
9. Radioimmunotherapy of human colon cancer xenografts using a dimeric single-chain Fv antibody construct. Pavlinkova G, Booth BJ, Batra SK, Colcher D. Clin Cancer Res; 1999 Sep 01; 5(9):2613-9. PubMed ID: 10499640 [Abstract] [Full Text] [Related]
10. Radioimmunotherapy of nude mice with intraperitoneally growing ovarian cancer xenograft utilizing 211At-labelled monoclonal antibody MOv18. Andersson H, Lindegren S, Back T, Jacobsson L, Leser G, Horvath G. Anticancer Res; 2000 Sep 01; 20(1A):459-62. PubMed ID: 10769696 [Abstract] [Full Text] [Related]
11. 131I radioimmunotherapy and fractionated external beam radiotherapy: comparative effectiveness in a human tumor xenograft. Barendswaard EC, O'Donoghue JA, Larson SM, Tschmelitsch J, Welt S, Finn RD, Humm JL. J Nucl Med; 1999 Oct 01; 40(10):1764-8. PubMed ID: 10520720 [Abstract] [Full Text] [Related]
12. [Experimental study of radioimmunotherapy for xenograft of human esophageal carcinoma]. Jiang P, Liu K, Chen M. Zhonghua Yi Xue Za Zhi; 1995 Sep 01; 75(9):543-4, 575. PubMed ID: 8556546 [Abstract] [Full Text] [Related]
13. Radioimmunotherapy of head and neck cancer xenografts using 131I-labeled antibody L19-SIP for selective targeting of tumor vasculature. Tijink BM, Neri D, Leemans CR, Budde M, Dinkelborg LM, Stigter-van Walsum M, Zardi L, van Dongen GA. J Nucl Med; 2006 Jul 01; 47(7):1127-35. PubMed ID: 16818947 [Abstract] [Full Text] [Related]
14. Therapeutic advantage of (90)yttrium- versus (131)iodine-labeled PAM4 antibody in experimental pancreatic cancer. Cardillo TM, Ying Z, Gold DV. Clin Cancer Res; 2001 Oct 01; 7(10):3186-92. PubMed ID: 11595713 [Abstract] [Full Text] [Related]
15. 211At radioimmunotherapy of subcutaneous human ovarian cancer xenografts: evaluation of relative biologic effectiveness of an alpha-emitter in vivo. Bäck T, Andersson H, Divgi CR, Hultborn R, Jensen H, Lindegren S, Palm S, Jacobsson L. J Nucl Med; 2005 Dec 01; 46(12):2061-7. PubMed ID: 16330571 [Abstract] [Full Text] [Related]
16. Influence of radiolabel on the in vivo processing of intact and fragmented anti-tumour monoclonal antibody. Smith A, Alberto R, Shubiger PA. J Nucl Biol Med (1991); 1994 Dec 01; 38(4 Suppl 1):54-8. PubMed ID: 7632768 [Abstract] [Full Text] [Related]
17. Comparison of systemic radiotherapy with I-131-labeled monoclonal antibody BW575/9 to external beam radiotherapy in human neuroblastoma xenografts. Sautter-Bihl ML, Wessely R, Bihl H. Strahlenther Onkol; 1993 Oct 01; 169(10):595-600. PubMed ID: 8235984 [Abstract] [Full Text] [Related]
18. Initial studies of monoclonal antibody PAM4 targeting to xenografted orthotopic pancreatic cancer. Alisauskus R, Wong GY, Gold DV. Cancer Res; 1995 Dec 01; 55(23 Suppl):5743s-5748s. PubMed ID: 7493339 [Abstract] [Full Text] [Related]
19. Tumor immunotherapy in the mouse with the use of 131I-labeled monoclonal antibodies. Zalcberg JR, Thompson CH, Lichtenstein M, McKenzie IF. J Natl Cancer Inst; 1984 Mar 01; 72(3):697-704. PubMed ID: 6583453 [Abstract] [Full Text] [Related]
20. [Influence of combination of low dosage 131I-labeled anti-carcinoembryonic antigen antibody C50 and 5-fluorouracil on tumor growth of colorectal cancer xenografts in nude mice]. Zheng CX, Zhan WH, Cai SR, He YL, Lin ZJ. Ai Zheng; 2003 Apr 01; 22(4):354-7. PubMed ID: 12703987 [Abstract] [Full Text] [Related] Page: [Next] [New Search]